Article

The mutational footprints of cancer therapies

2019-06-27

Abstract excerpt

Some cancer therapies damage DNA and cause mutations both in cancer and healthy cells of the patient 1 . These therapy-induced mutations may underlie some of the long-term and late side effects of the treatment, such as mental disabilities, organ toxicities and secondary neoplasms. Currently we ignore the mutation pattern and burden caused by different cancer treatments. Here we identify mutational signatures, or...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4b8dba36-2bbd-580d-b652-17e0ad004f15
DOI: 10.1101/683268

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The mutational footprints of cancer therapiesDOI 10.1101/683268Read

The mutational footprints of cancer therapies.Semantic proximity Read

Mutational signatures are markers of drug sensitivity of cancer cells.Semantic proximity Read

The Repertoire of Mutational Signatures in Human CancerSemantic proximity Read

The repertoire of mutational signatures in human cancer.Semantic proximity Read

Clinical and genomic characterization of mutational signatures across human cancers.Semantic proximity Read

Mutational signatures are markers of drug sensitivity of cancer cellsSemantic proximity Read

Signatures of mutational processes in human cancer.Semantic proximity Read

In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumorsSemantic proximity Read

Drug resistance: origins, evolution and characterization of genomic clones and the tumor ecosystem to optimize precise individualized therapySemantic proximity Read

Get the basics of genetic mutations in oncology.Semantic proximity Read

The signature of pharmaceutical sensitivity based on ctDNA mutation in eleven cancers.Semantic proximity Read

Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignanciesSemantic proximity Read